Integrated Multi-Cohort Transcriptomic Meta-Analysis and Molecular Docking Identify Core Dysregulated Hub Pathways and Therapeutic Ligands in Parkinson’s Disease
This study integrates multi-cohort transcriptomic meta-analysis and molecular docking to identify DRD2 and SLC18A3 as core hub genes for a novel Parkinson's disease diagnostic model and proposes donepezil and bromocriptine as potential therapeutic ligands targeting pyroptosis and neuroinflammation pathways.